微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -2.31% | -5675% | -478.69% | 42/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 0.61% | 203.39% | 916.67% | 32/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 0.06% | -94.17% | 100.76% | 34/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | -7.88% | -121.94% | -19600% | 44/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | -0.04% | -100.12% | 93.22% | 41/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | -0.59% | -102.4% | -157.28% | 41/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 1.03% | -90.39% | -97.13% | 32/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 35.91% | 168.19% | 7.07% | 3/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 33.54% | 147.89% | 36.23% | 3/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 24.62% | 268.01% | 129.66% | 4/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 10.72% | 2% | -19.94% | 4/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 13.39% | 51.99% | -1.03% | 22/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 13.53% | 2% | 102.24% | 13/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 6.69% | 71.1% | -24.06% | 19/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2020-12-31 | 8.81% | 34.71% | 125.32% | 32/51 | 10.95% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-06-30 | 3.91% | 11.71% | -40.21% | 19/51 | 2.48% | 金域医学 | 13.23% | 行业排名> |
| 2019-12-31 | 6.54% | 23.86% | 23.86% | 33/51 | 65.31% | 万邦医药 | 52.05% | 行业排名> |
| 2018-12-31 | 5.28% | 528.57% | 528.57% | 30/51 | -0.6% | 华大基因 | 48.52% | 行业排名> |
| 2017-12-31 | 0.84% | -92.81% | -76% | 36/51 | 1.73% | 华大基因 | 31.24% | 行业排名> |
| 2017-06-30 | 3.5% | -65.95% | -70.03% | 17/51 | 60.47% | 阳光诺和 | 13.99% | 行业排名> |
| 2016-12-31 | 11.68% | -62.56% | 13.62% | 17/51 | 23.06% | 南华生物 | 2848.07% | 行业排名> |
| 2016-06-30 | 10.28% | 2% | -67.05% | 5/51 | 4.57% | 南华生物 | 98.98% | 行业排名> |
| 2015-12-31 | 31.2% | -26.97% | -26.97% | 4/51 | 22.23% | 南华生物 | 82.46% | 行业排名> |